Prof Karl Hoffmann

PhD

Noder: Mae gwybodaeth ychwanegol neu manylach ar y fersiwn Saesneg o'r proffil hwn.

Grwpiau Ymchwil

Cyhoeddiadau

Padalino, G, Duggan, K, Mur, LAJ, Maillard, J-Y, Brancale, A & Hoffmann, KF 2024, 'Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms', MicrobiologyOpen, vol. 13, no. 6, e011. 10.1002/mbo3.70011
Stark, KA, Rinaldi, G, Costain, A, Clare, S, Tolley, C, Almeida, A, McCarthy, C, Harcourt, K, Brandt, C, Lawley, TD, Berriman, M, MacDonald, AS, Forde-Thomas, JE, Hulme, BJ, Hoffmann, KF, Cantacessi, C & Cortés, A 2024, 'Gut microbiota and immune profiling of microbiota-humanised versus wildtype mouse models of hepatointestinal schistosomiasis', Animal Microbiome, vol. 6, no. 1, 36. 10.1186/s42523-024-00318-3
Rawat, M, Padalino, G, Yeo, T, Brancale, A, Fidock, DA, Hoffmann, KF & Lee, MCS 2024 'Quinoxaline-Based Anti-Schistosomal Compounds Have Potent Anti-Malarial Activity' bioRxiv. 10.1101/2024.04.23.590861
Padalino, G, Celatka, C, Rienhoff Jr., HY, Kalin, JH, Cole, PA, Lassalle, D, Forde-Thomas, J, Chalmers, I, Brancale, A, Grunau, C & Hoffmann, K 2023, 'Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes', Wellcome Open Research, vol. 8, no. 146, 146. 10.12688/wellcomeopenres.18826.1
Chakroborty, A, Pritchard, D, Bouillon, ME, Cervi, A, Kraehenbuehl, R, Wild, C, Fenn, C, Holdsworth, PA, Capner, C, Padalino, G, Forde-Thomas, J, Payne, J, Smith, BG, Fisher, M, Lahmann, M, Baird, MS & Hoffmann, K 2023, 'Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica', Pharmaceutics, vol. 15, no. 7, 1869. 10.3390/pharmaceutics15071869
Mwy o gyhoeddiadau ar y Porth Ymchwil